Hayek Kallen Investment Management Novartis Ag Transaction History

Hayek Kallen Investment Management

$282 Million
Q3 2024

A detailed history of Hayek Kallen Investment Management transactions in Novartis Ag stock. As of the latest transaction made, Hayek Kallen Investment Management holds 40,320 shares of NVS stock, worth $4.31 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares

40,320

Previous 40,695 0.92%

Holding current value

$4.31 Million

Previous $4.33 Million 7.06%

% of portfolio

1.64%

Previous 1.62%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$106.13 - $120.89 $39,798 - $45,333	-375 Reduced 0.92%	40,320 $4.64 Million
Q2 2024 Jul 18, 2024	SELL	$92.57 - $107.37 $24,993 - $28,989	-270 Reduced 0.66%	40,695 $4.33 Million
Q1 2024 May 03, 2024	BUY	$95.27 - $108.47 $17,148 - $19,524	180 Added 0.44%	40,965 $3.96 Million
Q4 2023 Feb 08, 2024	SELL	$92.27 - $101.54 $12,548 - $13,809	-136 Reduced 0.33%	40,785 $4.12 Million
Q3 2023 Nov 07, 2023	SELL	$94.73 - $105.13 $8,146 - $9,041	-86 Reduced 0.21%	40,921 $4.17 Million
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $168,293 - $190,831	1,819 Added 4.64%	41,007 $4.14 Million
Q1 2023 May 08, 2023	SELL	$80.03 - $92.81 $92,594 - $107,381	-1,157 Reduced 2.87%	39,188 $3.61 Million
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $45,330 - $55,512	-600 Reduced 1.47%	40,345 $3.66 Million
Q3 2022 Oct 19, 2022	SELL	$74.61 - $87.26 $7,461 - $8,726	-100 Reduced 0.24%	40,945 $3.11 Million
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $72,468 - $84,375	-900 Reduced 2.15%	41,045 $3.47 Million
Q1 2022 May 09, 2022	SELL	$80.11 - $90.62 $70,096 - $79,292	-875 Reduced 2.04%	41,945 $3.68 Million
Q4 2021 Feb 08, 2022	SELL	$79.7 - $88.13 $9,165 - $10,134	-115 Reduced 0.27%	42,820 $3.75 Million
Q3 2021 Oct 06, 2021	SELL	$81.78 - $95.14 $31,730 - $36,914	-388 Reduced 0.9%	42,935 $3.51 Million
Q2 2021 Aug 12, 2021	BUY	$85.24 - $94.15 $10,569 - $11,674	124 Added 0.29%	43,323 $3.95 Million
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $2,171 - $2,560	26 Added 0.06%	43,199 $3.69 Million
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $2,185 - $2,644	-28 Reduced 0.06%	43,173 $4.08 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $18,070 - $20,020	-220 Reduced 0.51%	43,201 $3.76 Million
Q2 2020 Sep 10, 2020	SELL	$80.93 - $91.1 $31,400 - $35,346	-388 Reduced 0.89%	43,421 $3.79 Million
Q1 2020 Apr 22, 2020	SELL	$70.67 - $99.01 $62,118 - $87,029	-879 Reduced 1.97%	43,809 $3.61 Million
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $13,496 - $15,259	-160 Reduced 0.36%	44,688 $4.23 Million
Q3 2019 Nov 05, 2019	SELL	$85.54 - $94.26 $50,639 - $55,801	-592 Reduced 1.3%	44,848 $3.9 Million
Q2 2019 Jul 17, 2019	SELL	$75.4 - $92.8 $28,275 - $34,800	-375 Reduced 0.82%	45,440 $4.15 Million
Q1 2019 May 09, 2019	SELL	$75.32 - $86.15 $104,016 - $118,973	-1,381 Reduced 2.93%	45,815 $4.41 Million
Q4 2018 Jan 16, 2019	SELL	$73.66 - $82.02 $45,300 - $50,442	-615 Reduced 1.29%	47,196 $4.05 Million
Q3 2018 Nov 09, 2018	SELL	$66.94 - $77.43 $55,091 - $63,724	-823 Reduced 1.69%	47,811 $4.12 Million
Q3 2018 Nov 09, 2018	BUY	$66.94 - $77.43 $55,091 - $63,724	823 Added 1.72%	48,634 $3.93 Million
Q2 2018 Aug 03, 2018	SELL	$64.91 - $73.36 $53,420 - $60,375	-823 Reduced 1.69%	47,811 $3.61 Million
Q1 2018 May 10, 2018	SELL	$70.39 - $84.15 $121,774 - $145,579	-1,730 Reduced 3.43%	48,634 $3.93 Million
Q4 2017 Feb 08, 2018	SELL	$72.33 - $77.64 $37,973 - $40,761	-525 Reduced 1.03%	50,364 $4.23 Million
Q3 2017 Oct 25, 2017	BUY	$74.14 - $77.27 $3.77 Million - $3.93 Million	50,889	50,889 $4.37 Million

Others Institutions Holding NVS

# of Institutions

1,446

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.61M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $230B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hayek Kallen Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hayek Kallen Investment Management with notifications on news.

Account

Hayek Kallen Investment Management Novartis Ag Transaction History